Search

Your search keyword '"Baroncini D"' showing total 213 results

Search Constraints

Start Over You searched for: Author "Baroncini D" Remove constraint Author: "Baroncini D"
213 results on '"Baroncini D"'

Search Results

1. Signs and symptoms of COVID-19 in patients with multiple sclerosis

9. No evidence of disease activity (NEDA-3) and disability improvement after alemtuzumab treatment for multiple sclerosis: a 36-month real-world study

10. Extended interval dosing of natalizumab: is efficacy preserved?

12. Comparative effectiveness of dimethyl fumarate, teriflunomide, interferon-beta and glatiramer acetate on newly diagnosed patients: a propensity score-matched analysis from a multicenter Italian group

14. TREATMENT CHOICE AFTER 24 NATALIZUMAB DOSES IN PATIENTS WITH MULTIPLE SCLEROSIS: A PROSPECTIVE OBSERVATIONAL STUDY, THE TY-STOP

16. Comorbidities affect treatment choice and persistence in RRMS: a real-life multicenter study

17. Discontinuation of treatment with Natalizumab after 24 courses. Report from spontaneous, observational, prospective study (TYSTOP)

18. Management of multiple sclerosis patients after the 24th Natalizumab course: the Ty-STOP study

19. Clinical activity after fingolimod cessation: disease reactivation or rebound?

21. Perception of time in dyskinetic parkinsonian patients

22. Natalizumab Therapy, How to Treat How to Stop: The TY-STOP Study

23. How to treat MS patients after the 24 th natalizumab administration: the TY- STOP trial

24. How to treat MS patients after the 24th natalizumab administration: the TY-STOP trial

27. REPLAY Study Group. Subcutaneous interferon Beta-1a in pediatric multiple sclerosis: a retrospective study.J Child Neurol. 2013 Jul;28(7):849-56. doi: 10.1177/0883073813488828. Epub 2013 May 10

29. Sezione seconda: Sunti delle Comunicazioni presentate

39. P.15.5 SPLIT DOSAGE AND OTHER PREDICTORS OF QUALITY OF BOWEL CLEANSING IN PATIENTS ASSUMING A “VERY LOW VOLUME” PREPARATION FOR COLONOSCOPY: AN ITALIAN MULTICENTER STUDY USING THE ASSOCIATION OF SODIUM PICOSULPHATE AND MAGNESIUM CITRATE

43. P.1.149: NBI IN THE DIAGNOSIS OF GASTROINTESTINAL GRAFT-VERSUS-HOST DISEASE: A FEASIBLE TOOL FOR DETECTING MUCOSA AND VASCULAR ABNORMALITIES AT THE TIME OF ENDOSCOPY

Catalog

Books, media, physical & digital resources